Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Oncolytics Biotech Inc

+ Add to Watchlist


0.8800 CAD 0.0100 1.12%

As of 15:55:48 ET on 05/22/2015.

Company Profile for Oncolytics Biotech Inc (ONC)

Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.

Contact Information

Oncolytics Biotech Inc

Suite 210
1167 Kensington Crescent NW
Calgary, AB T2N 1X7
Phone: 1-403-670-7377
Fax: 1-403-283-0858

Key Executives for Oncolytics Biotech Inc (ONC)

Bradley G Thompson "Brad"Chairman/President/CEOKirk LookChief Financial Officer
Matthew C Coffey "Matt"COO/Co-FounderAlan J TuchmanSenior VP:Clinical/Chief Medical Ofcr
George M GillSenior VP:Regulatory AffairsMary Ann DillahuntyVP:Intellectual Property

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil